Truvelog Mix 30 is an insulin medicine used to treat patients from 10 years of age who have diabetes and need insulin to keep their blood glucose (sugar) level controlled. Truvelog Mix 30 is a ‘biosimilar medicine’. This means that Truvelog Mix 30 is highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU. The reference medicine for Truvelog Mix 30 is NovoMix 30. For more information on biosimilar medicines, see [here](/en/biosimilar-medicines-overview). Truvelog Mix 30 contains the active substance insulin aspart combined with protamine to make it longer acting.
Therapeutic Indication
### Therapeutic indication Truvelog Mix 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above.
Therapeutic Area (MeSH)
ATC Code
A10AD05
ATC Item
insulin aspart
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| insulin aspart | N/A | 门冬胰岛素 |
EMA Name
Truvelog Mix 30
Medicine Name
Truvelog Mix 30
Aliases
N/A